The Cigna Group
CI
$352.39
$3.611.04%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 48.07B | 45.85B | 45.28B | 43.45B | 42.90B |
| Total Other Revenue | 3.01B | 3.18B | 3.33B | 3.02B | 2.86B |
| Total Revenue | 51.08B | 49.03B | 48.61B | 46.46B | 45.76B |
| Cost of Revenue | 44.54B | 42.57B | 42.48B | 40.51B | 40.06B |
| Gross Profit | 6.54B | 6.47B | 6.14B | 5.96B | 5.70B |
| SG&A Expenses | 3.80B | 3.59B | 3.44B | 3.55B | 3.48B |
| Depreciation & Amortization | 451.00M | 454.00M | 455.00M | 459.00M | 457.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.79B | 46.61B | 46.37B | 44.51B | 44.00B |
| Operating Income | 2.29B | 2.43B | 2.24B | 1.95B | 1.76B |
| Income Before Tax | 188.00M | 1.84B | 1.88B | 1.60B | 1.36B |
| Income Tax Expenses | -919.00M | 391.00M | 374.00M | 295.00M | 136.00M |
| Earnings from Continuing Operations | 1.11B | 1.45B | 1.51B | 1.31B | 1.22B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -78.00M | -41.00M | -50.00M | -39.00M | -29.00M |
| Net Income | 1.03B | 1.41B | 1.46B | 1.27B | 1.19B |
| EBIT | 2.29B | 2.43B | 2.24B | 1.95B | 1.76B |
| EBITDA | 3.06B | 3.20B | 3.00B | 2.70B | 2.50B |
| EPS Basic | 3.49 | 4.79 | 4.96 | 4.28 | 3.91 |
| Normalized Basic EPS | 3.86 | 4.27 | 3.84 | 3.25 | 2.88 |
| EPS Diluted | 3.49 | 4.74 | 4.92 | 4.24 | 3.90 |
| Normalized Diluted EPS | 3.86 | 4.23 | 3.81 | 3.22 | 2.88 |
| Average Basic Shares Outstanding | 294.57M | 294.06M | 294.51M | 295.71M | 305.41M |
| Average Diluted Shares Outstanding | 294.57M | 297.13M | 296.88M | 299.00M | 305.41M |
| Dividend Per Share | 1.23 | 1.23 | 1.23 | 1.23 | 1.12 |
| Payout Ratio | 34.79% | 25.71% | 24.79% | 29.04% | 28.00% |
